Risk of fingolimod rebound after switching to cladribine or rituximab in multiple sclerosis
Article in Multiple Sclerosis and Related Disorders (April 2022)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Multiple Sclerosis and Related Disorders (April 2022)
Article in Reactions Weekly (March 2021)